维拉德美制药
MANE
108.82
-6.25
-5.43%
维拉德美制药
US · MANE
#2148 按市值排名
上市于 2026
108.82
-6.25
-5.43%
实时 - 追踪5344个代码 - 心跳于323秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了2家。
- 机构持股总比例下降了2.8个百分点。
机构持股
- 机构持股比例
- 95.70% -2.76pp
- 机构数量
- 190 +2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund33.66%
Hedge Fund30.45%
VC/PE Fund30.25%
Individual/Insider2.67%
Public Company0.66%
Sovereign Wealth Fund0.35%
Government Pension Fund0.17%
Private Company0.16%
Other1.63%
主要股东 截至 2026-05-01
Longitude Capital Management Co., LLC
11.14% · 4.65M 股
Montanova Capital, LLC
8.90% · 3.72M 股
FMR
7.67% · 3.20M 股
SR One Capital Management, LP
4.98% · 2.08M 股
Deep Track Capital, LP
4.79% · 2.00M 股
Prospect Hill Growth Partners, L.P.
4.57% · 1.91M 股
Citadel Advisors LLC
4.49% · 1.88M 股
Artal Group S.A.
3.96% · 1.66M 股
BlackRock
3.81% · 1.59M 股
Viking Global Investors LP
3.74% · 1.56M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 25次买入 · 7次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Longitude Capital Management Co., LLC | -- | 11.14% |
| Vladimir Coric | Independent Director | 1.56% |
| John Childs | Independent Director | 0.46% |
| Reid Waldman | Chief Executive Officer | 0.41% |
| Timothy Durso | President | 0.19% |
| Jane Grant-Kels | Independent Director | 0.05% |
| Prospect Hill Growth Partners, L.P. | -- | -- |
| David Friedman | Independent Director | -- |
| Michael Greco | General Counsel | -- |
| Montanova Capital, LLC | -- | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-31 | David Hollander | -- | Other Acquisition | +9,650 | -- |
| 2026-08-31 | David Hollander | -- | Other Derivative Acquisition | +19,300 | $97.51 |
| 2026-08-19 | Montanova Capital, LLC | -- | Derivative Exercise and Retained | +300,000 | -- |
| 2026-08-18 | Montanova Capital, LLC | -- | Private Disposition | -750,000 | $107.25 |
| 2026-08-16 | Reid Waldman | Chief Executive Officer | Open Market Disposition | -64,048 | $106.72–111.28 |
| 2026-08-16 | Reid Waldman | Chief Executive Officer | Derivative Exercise and Sale | -3,452 | $12.19–106.72 |
| 2026-08-16 | Timothy Durso | President | Open Market Disposition | -40,048 | $106.71–111.28 |
| 2026-08-16 | Timothy Durso | President | Derivative Exercise and Sale | -3,452 | $12.19–106.71 |
| 2026-08-11 | John Childs | Independent Director | Open Market Disposition | -100,000 | $106.14–108.24 |
| 2026-08-11 | John Childs | Independent Director | Intent to Sell (Form 144) | -100,000 | -- |
| 2026-04-30 | Montanova Capital, LLC | -- | Other Derivative Acquisition | +300,000 | -- |
| 2026-04-30 | Seven Fleet Capital Management LP | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-02-05 | Montanova Capital, LLC | -- | Open Market Acquisition | +264,185 | $34.25–39.80 |
| 2026-02-04 | Prospect Hill Growth Partners, L.P. | -- | Derivative Exercise and Retained | +1,907,889 | -- |
| 2026-02-04 | John Childs | Independent Director | Private Acquisition | +294,117 | $17.00 |
| 2026-02-04 | Longitude Capital Management Co., LLC | -- | Private Acquisition | +1,075,000 | $17.00 |
| 2026-02-04 | Longitude Capital Management Co., LLC | -- | Derivative Exercise and Retained | +3,578,873 | -- |
| 2026-02-04 | Vladimir Coric | Independent Director | Private Acquisition | +117,646 | $17.00 |
| 2026-02-04 | Vladimir Coric | Independent Director | Derivative Exercise and Retained | +638,262 | -- |
| 2026-02-04 | Reid Waldman | Chief Executive Officer | Derivative Exercise and Retained | +1,437 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:13 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
维拉德美制药 讨论区 0 条评论